News for Cipher Pharmaceuticals Inc. (CPH.TO)

Published at

May 12, 2025 7:31 PM

by gurufocus.com

positive

positive

Canaccord Adjusts Price Target for Cipher Pharmaceuticals (CPHRF) | CPHRF Stock News

Canaccord has revised its price target for Cipher Pharmaceuticals (CPHRF), increasing it from C$12.50 to C$13 while maintaining a Hold rating on the company's s

CPHRF CPH.TO

Read more →
Published at

May 10, 2025 9:05 AM

by gurufocus.com

positive

positive

Cipher Pharmaceuticals Inc (CPHRF) Q1 2025 Earnings Call Highlights: Revenue Surges Amid Strategic Moves

Total Net Revenue: $12 million in Q1 2025, a 105% increase from Q1 2024.Natroba Business Revenue: $6.7 million in Q1 2025.Gross Margin (Natroba): $5.8 million

CPHRF CPH.TO

Read more →
Published at

May 10, 2025 7:19 AM

by gurufocus.com

positive

positive

Q1 2025 Cipher Pharmaceuticals Inc Earnings Call Transcript

May 09, 2025 / 12:30PM GMTOperator Good morning, ladies and gentlemen. Thank you for standing by. Welcome to the Cipher Pharmaceuticals quarterly conference cal

CPHRF CPH.TO

Read more →
Published at

Apr 15, 2025 11:22 PM

by gurufocus.com

positive

positive

Cipher Pharmaceuticals (TSX:CPH) in Donville Kent 2024 Q2

\nInvestment rationale centers on strategic acquisitions and cash-rich balance sheet.Market positioning strengthened by recent acquisition of Natroba and US sale

CPH.TO

Read more →
Published at

Apr 15, 2025 2:47 PM

by gurufocus.com

positive

positive

NEUPATH APPOINTS STEPHEN LEMIEUX AS PRESIDENT TO DRIVE NEXT PHASE OF STRATEGIC GROWTH | EDSA Stock News

Stephen Lemieux appointed as President of NeuPath Health Inc. (TSXV:NPTH), effective May 1, 2025. Lemieux brings over 20 years of experience in healthca

NPTH.V EDSA CPH.TO

Read more →
Published at

Apr 5, 2025 12:00 AM

by gurufocus.com

mixed

mixed

Edesa Biotech Announces Chief Financial Officer Transition

TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therape

EDSA RX.V CPHRF CPH.TO BIOYF

Read more →
Published at

Apr 4, 2025 10:38 PM

by manilatimes.net

mixed

mixed

Edesa Biotech Announces Chief Financial Officer Transition

**media[586399]**

EDSA RX.V CPHRF CPH.TO BIOYF

Read more →
Published at

Mar 22, 2025 3:57 AM

by gurufocus.com

positive

positive

Cipher Pharmaceuticals Inc (TSX:CPH) Q4 2024 Earnings Report Preview: What To Expect

Cipher Pharmaceuticals Inc (TSX:CPH) is set to release its Q4 2024 earnings on Mar 18, 2025. The consensus estimate for Q4 2024 revenue is $17.92 million, and t

CPHRF CPH.TO

Read more →
Published at

Mar 21, 2025 11:31 PM

by gurufocus.com

positive

positive

Cipher Pharmaceuticals Inc (TSX:CPH) Q4 2024 Earnings Report Preview: What To Expect

Cipher Pharmaceuticals Inc (TSX:CPH) is set to release its Q4 2024 earnings on Mar 19, 2025. The consensus estimate for Q4 2024 revenue is $17.92 million, and t

CPHRF CPH.TO

Read more →
Published at

Mar 20, 2025 8:02 AM

by gurufocus.com

positive

positive

Cipher Pharmaceuticals Inc (CPHRF) Q4 2024 Earnings Call Highlights: Record Revenue Surge and Strategic Growth Initiatives

Total Net Revenue (Q4 2024): $11.8 million, up 141% from the prior year.Product Revenue (Q4 2024): $10.5 million, up 209% from the prior year.Natroba Revenue (

CPHRF CPH.TO

Read more →
Published at

Mar 20, 2025 6:02 AM

by gurufocus.com

positive

positive

Q4 2024 Cipher Pharmaceuticals Inc Earnings Call Transcript

Mar 19, 2025 / 12:30PM GMTOperator Good morning, ladies and gentlemen. Thank you for standing by. Welcome to the Cipher Pharmaceuticals quarterly conference cal

CPHRF CPH.TO

Read more →
Published at

Mar 19, 2025 4:06 PM

by seekingalpha.com

neutral

neutral

Cipher Pharmaceuticals Inc. 2024 Q4 - Results - Earnings Call Presentation (OTCMKTS:CPHRF)

The following slide deck was published by Cipher Pharmaceuticals Inc.

CPHRF CPH.TO

Read more →
Published at

Mar 19, 2025 4:04 PM

by seekingalpha.com

positive

positive

Cipher Pharmaceuticals Inc. (CPHRF) Q4 2024 Earnings Call Transcript

Cipher Pharmaceuticals Inc. (OTCQX:CPHRF) Q4 2024 Earnings Conference Call March 19, 2025 8:30 AM ETCompany ParticipantsCraig Mull - Interim CEORyan...

CPHRF CPH.TO

Read more →
Published at

Feb 10, 2025 4:30 AM

by seekingalpha.com

mixed

mixed

Donville Kent Asset Management January 2025 Commentary

Donville Kent Asset Management's DKCI Fund returned 102.75% in 2024. The fund has performed well since bottoming in October 2023. Click here to read the full letter.

GOOGL CPH.TO

Read more →
Published at

Nov 9, 2024 8:00 PM

by gurufocus.com

positive

positive

Cipher Pharmaceuticals Inc (CPHRF) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Plans

Total Net Revenue (Q3 2024): $10.4 million, a 71% increase compared to the same quarter in the prior year.Total Net Revenue (9 months ended September 30, 2024)

CPHRF CPH.TO

Read more →
Published at

Nov 9, 2024 6:17 PM

by gurufocus.com

positive

positive

Q3 2024 Cipher Pharmaceuticals Inc Earnings Call Transcript

Nov 08, 2024 / 01:30PM GMTOperator Good morning, ladies and gentlemen. And thank you for standing by. Welcome to the Cipher Pharmaceuticals quarterly conference

CPHRF CPH.TO

Read more →
Published at

Nov 6, 2024 1:38 PM

by gurufocus.com

positive

positive

Earnings To Watch: Cipher Pharmaceuticals Inc (TSX:CPH) Reports Q3 2024 Result

Cipher Pharmaceuticals Inc (TSX:CPH) is set to release its Q3 2024 earnings on Nov 7, 2024. The consensus estimate for Q3 2024 revenue is $14.60 million, and th

CPHRF CPH.TO

Read more →
Published at

May 13, 2024 7:03 AM

by gurufocus.com

positive

positive

Q1 2024 Cipher Pharmaceuticals Inc Earnings Call Transcript

May 10, 2024 / 12:30PM GMTOperator Good morning, ladies and gentlemen, and thank you for standing by. Welcome to the Cipher Pharmaceuticals quarterly conference

CPHRF CPH.TO

Read more →
Published at

May 10, 2024 4:06 PM

by seekingalpha.com

positive

positive

Cipher Pharmaceuticals Inc. (CPHRF) Q1 2024 Earnings Call Transcript

Cipher Pharmaceuticals Inc. (OTCQX:CPHRF) Q1 2024 Earnings Conference Call May 10, 2024 8:30 AM ETCompany ParticipantsCraig J.

CPHRF CPH.TO

Read more →
Published at

May 10, 2024 1:43 AM

by marketscreener.com

neutral

neutral

Cipher Pharmaceuticals : Financial Document

MANAGEMENT'S DISCUSSION AND ANALYSIS For the three months ended March 31, 2024 MANAGEMENT'S DISCUSSION AND ANALYSIS ...

CPHRF CPH.TO

Read more →